Abstract
This chapter highlights the value of combined experimental and computational approaches in describing the effect of small changes in molecular structures on solid-state structure and overall extent of solid-state diversity. Experimental solid form screening for an atypical antipsychotic agent clozapine yielded four novel physical forms including monohydrate, two crystalline solvates and an amorphous phase. The crystal energy landscape confirmed that there are no alternative packing arrangements which are thermodynamically competitive with an only experimentally obtained anhydrous form. Crystal structure prediction studies provided an explanation for different solid-state diversity of olanzapine (60 solid forms) as compared to clozapine (4 solid forms) as well as presence/absence of centrosymmetric dimer in the crystal structures of olanzapine and clozapine polymorphs respectively. Another set of molecules differing in one methyl group i.e. an anti-depressant agent amoxapine and a tranquiliser agent loxapine exhibited monomorphism and polymorphism respectively. Crystal structure prediction studies and packing efficiency calculations revealed that the methyl group in loxapine is playing a significant role in increasing the range of accessible solid forms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Accelrys (2010) Pipeline pilot in chemistry collection: basic chemistry user guide. Accelrys Inc., 5005 Wateridge Vista Drive, San Diego, CA 92121
Ashby CJ, Wang R (1996) Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24:349–394
Bastin RJ, Bowker MJ, Slater BJ (2000) Salt selection and optimisation procedures for pharmaceutical new chemical entities. Org Process Res Dev 4:427–435
Bhardwaj RM, Price LS, Price SL, Reutzel-Edens SM, Miller GJ, Oswald IDH, Johnston BF, Florence AJ (2013) Exploring the experimental and computed crystal energy landscape of olanzapine. Cryst Growth Des 13:1602–1617
Boultif A, Louer D (1991) Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method. J Appl Crystallogr 24:987–993
Braun DE, Karamertzanis PG, Arlin J-B, Florence AJ, Kahlenberg V, Tocher DA, Griesser UJ, Price SL (2010) Solid-state forms of β-resorcylic acid: How exhaustive should a polymorph screen be? Cryst Growth Des 11:210–220
Capuano B, Crosby IT, Gable RW, Lloyd EJ (2000) N-Piperonyl analogue of the atypical antipsychotic clozapine. Acta Crystallogr C 56:339–340
Capuano B, Crosby IT, Egan SJ, Fallon GD, Lloyd EJ, Neve JE (2005) 4-Chloro-N-[4-(8-chloro-5H-dibenzo[b, e][1,4]diazepin-11-yl)-1-methylpiperazinio]benzamidate dichloromethane solvate. Acta Crystallogr Sect E 61:o20–o22
Capuano B, Crosby I, Forsyth C, McRobb F, Moudretski V, Taylor D, Vom A, Yuriev E (2010) New hybrids of clozapine and haloperidol and their isosteric analogues: synthesis, X-ray crystallography, conformational analysis and preliminary pharmacological evaluation. Struct Chem 21:613–628
Clark SJ, Segall MD, Pickard CJ, Hasnip PJ, Probert MJ, Refson K, Payne MC (2005) First principles methods using CASTEP. Zeitschrift Fur Kristallographie 220:567–570
Coelho A (2003) Indexing of powder diffraction patterns by iterative use of singular value decomposition. J Appl Crystallogr 36:86–95
Cosulich DB, Lovell FM (1977) The X-ray crystal structures of loxapine 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b, f][1,4]oxazepine and amoxapine {2-chloro-11-(1-piperazinyl)dibenz[b, f][1,4]oxazepine}. Acta Crystallogr B 33:1147–1154
Desiraju GR (1991) The C-H.cntdot.cntdot.cntdot.O hydrogen bond in crystals: What is it? Acc Chem Res 24:290–296
Desiraju GR (2002) Hydrogen bridges in crystal engineering: interactions without borders. Acc Chem Res 35:565–573
Dunitz JD, Gavezzotti A (2005) Toward a quantitative description of crystal packing in terms of molecular pairs: application to the hexamorphic crystal system, 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile. Cryst Growth Des 5:2180–2189
Dupont L, Liegeois J-F (2003) 8-chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzoxazepine. Acta Crystallogr Sect E 59:o1962–o1963
Dupont L, Liegeois J-F, Rogister F, Delarge J (1996) 8-chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzodiazepine. Acta Crystallogr Sect C 52:391–393
Fillers JP, Hawkinson SW (1982a) The structure of 4-(2-chlorodibenz[b, f][1,4]oxazepin-11-yl)-1-methyl-1H-piperazinium succinate monohydrate (loxapine succinate monohydrate). Acta Crystallogr Sect B 38:3041–3045
Fillers JP, Hawkinson SW (1982b) The structure of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b, e][1,4]diazepine dihydrobromide, clozapine dihydrobromide. Acta Crystallogr Sect B 38:1750–1753
Florence AJ, Shankland N, Shankland K, David WIF, Pidcock E, Xu X, Johnston A, Kennedy AR, Cox PJ, Evans JSO, Steele G, Cosgrove SD, Frampton CS (2005) Solving molecular crystal structures from laboratory X-ray powder diffraction data with DASH: the state of the art and challenges. J Appl Crystallogr 38:249–259
Florence AJ, Johnston A, Price SL, Nowell H, Kennedy AR, Shankland N (2006) An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine. J Pharm Sci 95:1918–1930
Florence AJ, Bedford CT, Fabbiani FPA, Shankland K, Gelbrich T, Hursthouse MB, Shankland N, Johnston A, Fernandes P (2008) Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue. CrystEngComm 10:811–813
Florence AJ, Bardin J, Johnston B, Shankland N, Griffin TAN, Shankland K (2009) Structure determination from powder data: Mogul and CASTEP. Zeitschrift Fur Kristallographie 215–220
Frank A (2002) The cambridge structural database: a quarter of a million crystal structures and rising. Acta Crystallogr Sect B 58:380–388
Greenbla E, Osterber A (1968) Pharmacodynamic actions of 2-chloro-11-(1-piperazinyl)dibenz [b, f] 1,4 oxazepine: a new psychoactive agent. Fed Proc 27:438
Holden JR, Du Z, Ammon HL (1993) Prediction of possible crystal structures for C-, H-, N-, O-, and F- containing organic compounds. J Comput Chem 14:422–437
Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1987) Incidence worldwide of schizophrenia. Br J Psychiatry 151:408–409
Kazantsev AV, Karamertzanis PG, Adjiman CS, Pantelides CC (2011a) Efficient handling of molecular flexibility in lattice energy minimization of organic crystals. J Chem Theor Comput 7:1998–2016
Kazantsev AV, Karamertzanis PG, Adjiman CS, Pantelides CC, Price SL, Galek PTA, Day GM, Cruz-Cabeza AJ (2011b) Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction. Int J Pharm 418:168–178
Kazantsev AV, Karamertzanis PG, Pantelides CC, Adjiman CS (2011c) Crystaloptimizer: an efficient algorithm for lattice energy minimization of organic crystals using isolated-molecule quantum mechanical calculations. Process Systems Engineering, Wiley-VCH Verlag GmbH & Co. KGaA, Germany, pp 1–42
Latimer CN (1969) Neuropharmacologic evaluation of oxilapine a potent psychoactive agent. J Pharmacol Exp Ther 166:151–162
McKinnon JJ, Spackman MA, Mitchell AS (2004) Novel tools for visualizing and exploring intermolecular interactions in molecular crystals. Acta Crystallogr Sect B 60:627–668
MOE (2002) Chemical computing group, 1010 Sherbrooke St. W, Montreal, Quebec, H3A 2R7. Qubec, Canada
Petcher TJ, Weber H-P (1976) Conformations of some semi-rigid neuroleptic drugs. Part 1. Crystal structures of loxapine, clozapine, and HUF-2046 monohydrate {2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, f][1,4]oxazepine, 8-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine, and 2-chloro-11(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine monohydrate}. J Chem Soc Perkin Trans 2:1415–1420
Price SL, Leslie M, Welch GWA, Habgood M, Price LS, Karamertzanis PG, Day GM (2010) Modelling organic crystal structures using distributed multipole and polarizability-based model intermolecular potentials. Phys Chem Chem Phys 12:8478–8490
SIMCA (2012) Multivariate analysis software, version 13.0.0.0., Umetrics Ltd. MKS Instruments UK Ltd., Unit 3–4, Cowley Way, Weston Road, Crewe, Cheshire, CW1 6AG, UK
Siva Lakshmi D, Prasunamba PL, Ravikumar KBS (2011) Solid state characterization of clozapine monohydrate. Struct Chem Commun 2:101–104
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bhardwaj, R.M. (2016). Exploring the Physical Form Landscape of Clozapine, Amoxapine and Loxapine. In: Control and Prediction of Solid-State of Pharmaceuticals . Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-319-27555-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-27555-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27554-3
Online ISBN: 978-3-319-27555-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)